Suchergebnisse - "Lenalidomide"

PubPharm (2.740)

1

Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Jedlowski, P. | DuPont, J.

2

Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

enthalten in: Photodermatology, photoimmunology & photomedicine | 2024

von De Novellis, D. | Raimondo, A. | Serio, B. | +4

3

Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain

enthalten in: European journal of haematology | 2024

von Lehne, M. | Kortüm, K. | Ramasamy, K. | +10

4

Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?

enthalten in: Blood cancer journal | 2024

von Abdallah, M. | Reichard, K. | Gangat, N. | +1

5

Combining lenalidomide with erythropoiesis stimulating agents : a party of one

enthalten in: Leukemia | 2024

von Chandhok, N. | Sekeres, M.

6

Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden : An analysis using linked Nordic registries

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Abildgaard, N. | Anttila, P. | Waage, A. | +7

7

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma : A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Oriol, A. | Dimopoulos, M. | Schjesvold, F. | +12

8

Cereblon-Targeting Ligase Degraders in Myeloma : Mechanisms of Action and Resistance

enthalten in: Hematology/oncology clinics of North America | 2024

von Lee, H. | Neri, P. | Bahlis, N.

9

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma : an indirect treatment comparison

enthalten in: Leukemia & lymphoma | 2024

von Weisel, K. | Dimopoulos, M. | Beksac, M. | +7

10

enthalten in: Dermatologie (Heidelberg, Germany) | 2024

von Sunderkötter, C. | Bruns, T. | Pfeiffer, C.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[274]